Managing Ultrafiltration in Dialysis Patients with Pleural Effusion

Initial Assessment and Dry Weight Optimization

The American Journal of Kidney Diseases recommends determining if the pleural effusion is related to volume overload versus other etiologies before adjusting the dialysis prescription, as fluid overload is the most common cause of pleural effusions in dialysis patients, but infection, malignancy, uremia, and hemorrhagic causes must be excluded 3, 4
The European Respiratory Journal suggests performing echocardiography to assess cardiac filling pressures and volume status noninvasively 4
The American Journal of Kidney Diseases recommends evaluating the current estimated dry weight (EDW) and considering gentle probing of the target weight over 4-12 weeks (potentially up to 6-12 months in patients with diabetes or cardiomyopathy), as patients can have "silent overhydration" with fluid excess despite absence of gross clinical evidence of volume expansion 5, 6

The American Journal of Kidney Diseases recommends limiting ultrafiltration rates to ≤10 mL/kg/hour to minimize cardiovascular risk and organ hypoperfusion, and extending treatment duration to achieve adequate fluid removal while avoiding intradialytic hypotension and cardiovascular complications 1, 2
The American Journal of Kidney Diseases suggests reducing the UFR toward the end of dialysis as dry weight is approached, when vascular refilling from tissue spaces slows, and extending dialysis treatment duration rather than increasing UF rate when larger fluid volumes need removal 5, 6, 1, 2

The American Journal of Kidney Diseases recommends performing isolated ultrafiltration temporally separated from diffusive clearance, as it results in prompt increases in stroke index, cardiac index, pulmonary artery wedge pressure, and mean arterial pressure, and must extend total dialysis duration to compensate for time lost for diffusive clearance 1, 2
The American Journal of Kidney Diseases suggests reducing dialysate temperature from 37°C to 34-35°C to increase peripheral vasoconstriction and cardiac output, which decreases symptomatic hypotension incidence, and switching from acetate to bicarbonate-buffered dialysate to minimize hypotension 1, 2

The European Respiratory Journal recommends considering both dialytic and non-dialytic interventions for patients with persistent pleural effusions despite optimized dialysis, including increasing treatment frequency or duration, and implementing strict dietary sodium restriction 3, 7, 4
The Kidney International suggests maximizing peritoneal UF using icodextrin for long dwells, shortening glucose-based solution dwells, and using diuretics if residual kidney function is present, and considering slow ultrafiltration for longer than the standard 4 hours three times weekly 7, 5, 6

The American Journal of Kidney Diseases warns that overly aggressive ultrafiltration causes more harm than benefit in this vulnerable population, and hypotension during dialysis impairs tissue perfusion and can compromise dialysis adequacy, and interdialytic weight gain >4.8% of body weight is associated with increased mortality 5, 6, 1, 2, 9

The American Journal of Kidney Diseases recommends particularly cautious UF management in patients with cardiac failure or cardiomyopathy, as the process of approaching dry weight takes longer in these patients, and plasma refilling can be low even in the presence of expanded volume 5, 6